Immunosuppression and recovery of drug-impaired host resistance against Candida albicans infection by oxoglaucine

Pharmacological Research

Volumn 41, Issue 1, 2000, Pages 99-105

  Ivanovska, Nina ^a   Hristova, Maria ^a   Philipov, Stefan ^a  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

Candida albicans infection; Cyclophosphamide; Oxoglaucine; Prednisolone

Indexed keywords

CYCLOPHOSPHAMIDE; OXOGLAUCINE; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL PROLIFERATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HOST RESISTANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE; MORTALITY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL;

EID: 0033988374     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0567     Document Type: Article

References (23)

1. Meunier F, Aoun H, Bitar N. Candidemia in immunocompromized patients. Clin Infect Dis. 1992;120-125.
2. Trends Microbiol. 6:1994;202-206.
3. Odds F C. Candida and Candidiosis. 1988;Billière Tindall, London: p. 124-52.
4. Romani L, Puccetti P, Bistoni F. Biological role of helper T-cell subsets in candidiasis. Chem Immunol. 63:1996;113-137.
5. Ivanovska N, Philipov S, Georgieva P. Immunopharmacological activity of aporphinoid alkaloid oxoglaucine. Pharmacol Res. 35:1997;267-272.
6. Ivanovska N, Philipov S. A low dose immunorestorative effect of aporphinoid alkaloid oxoglaucine on experimentally immunosuppressed and infected mice. Methods Find Exp Clin Pharmacol. 19:1997;579-583.
7. Philipov S, Ivanovska N, Nikolova P. Glaucine analogues as inhibitors of mouse splenoyte activity. Pharmazie. 53:1998;694-698.
8. Mosmann T R. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assay. J Immun Methods. 65:1983;55-63.
9. Papadimitriou J M, Ashman R B. The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain. J Pathol. 150:1986;257-265.
10. Ashman R B. Mouse candidiasis. Immunogenetics. 25:1987;200-203.
11. +cells in acute, systemic murine candidosis. J Leokocyte Biol. 51:1992;305-306.
12. +T helper subset election in mice with candidiasis. J Immunol. 158:1997;2356-2362.
13. Mencacci A, Cenci E, Bistoni F, Bacci A, Del Sero G, Montagnoli C, Fè d'Ostiani C, Romani L. Specific and non-specific immunity to Candida albicans: a lesson from genetically modified animals. Res Immunol. 149:1998;352-361.
14. Romani L, Bistoni F, Mencacci A, Cenci E, Spaccapelo R, Puccetti P. IL12 i. Candida albicans. 146:1996;532-538.
15. Cenci E, Mencacci A, Spaccapelo R, Tonnetti L, Enssle K-H L, Puccetti P, Romani L, Bistoni F. T helper type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis. 171:1995;1279-1288.
16. +subset expression in murine candidiasis. J Immunol. 150:1993;925-931.
17. Romani L, Howard D H. Mechanisms of resistance to fungal infection. Curr Opin Immunol. 7:1995;517-523.
18. Ashman R B, Papadimitriou J M. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev. 59:1995;646-672.
19. Goto M, Mitsuoka A, Sugiyma M, Kitano M. Enhancement of delayed hypersensitivity reaction with varieties of anticancer drugs. J Exp Med. 154:1981;204-209.
20. Dum C J, Galinet L A, Gibbons A J, Shielols S K. Murine delayed-type hypersensitivity granuloma: an improved model for the identification and evaluation of different classes of anti-arthritic drugs. Int J Immunopharmacol. 12:1990;899-904.
21. Hadden J W. T cell adjuvants. Int J Immunopharmacol. 16:1994;703-710.
22. Garner R E, Domer J E. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis. Infect Immun. 62:1994;738-741.
23. Carrow E W, Domer J E. Immunoregulation in experimental murine candidiasi s: specific suppression induced by Candida albicans cell wall glycoprotein. Infect Immun. 49:1985;172-181.